Supergenix MCED
Early Detection Matters
Detect Earlier. Act Sooner.
Supergenix Multi Cancer Early Detection (MCED) offers an advanced approach to screening for signals associated with multiple cancers, helping support earlier detection and more informed next steps for your health.
Your Early Cancer Detection
Who should Test?
Individuals with a Family History of Cancer
The Multi-Cancer Early Detection (MCED) screening detects multiple types of cancer through a simple blood test. This approach has the potential to improve early diagnosis, reduce cancer-related deaths, and enhance overall patient outcomes.
By analysing biological signals, such as mced fragments released by tumours into the bloodstream, MCED can identify the presence of cancer even before symptoms develop.
Its primary goal is to detect cancers at an early stage, when treatment is often more effective and survival rates are higher.
Unlike traditional screening methods that focus on a single cancer type, MCED can screen for several cancers simultaneously. This approach has the potential to improve early diagnosis, reduce cancer-related deaths, and enhance overall patient outcomes.
